|
T.TH
|
Here we go again. Always this underlying thought, almost racist. If they have...
|
|
T.TH
|
There is no real positive news. Only talks about great potential, but no hard...
|
|
T.TH
|
What else do you want him to do? There are limits to what a CEO can legally...
|
|
T.TH
|
CYDY is a fraudulent company that found its way into the crazy US penny...
|
|
T.TH
|
I need to requote myself to put the record straight here... So much bad faith...
|
|
T.TH
|
Here is my full original post describing how everything is supposed to go...
|
|
T.TH
|
So, in theory, we are into another cycle at a higher dose of TH1902 now, this...
|
|
T.TH
|
I think Levesque just opened himself a path to make better decisions. He will...
|
|
T.TH
|
It is clear to me that the option of going for it alone is still the most...
|
|
T.TH
|
There is a market for HIV patients having both lipodystrophy and NAFLD/NASH...
|
|
T.TH
|
Look at my previous post. Sortilin is recycled, it's true. But if you...
|
|
T.TH
|
Impossible. Anyways, binding to sotilin leads to endocytosis. The interesting...
|
|
T.TH
|
28 weeks has always been an estimation. It could be shorter or longer...
|
|
T.TH
|
I found a good article on sortilin expression in breast cancer. Thera is...
|
|
T.TH
|
The good news is that few shareholders are willing to sell at the actual...
|
|
T.TH
|
If the phase Ia is over before the end of 2021, I expect the phase Ib to...
|
|
T.TH
|
In the last KOL presentation in June, Marsolais said that they expect to...
|
|
T.TH
|
You are right with Paul effusiveness during the last chat, remember his "...
|
|
T.TH
|
I reread the oncology part of the corporate presentation. Strangely, not a...
|
|
T.TH
|
If the goal is to have it up every week for any new potential investor coming...
|